用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺治疗的小鼠中L1210白血病的抗原变化 - Suppr

Suppr

超能文献

Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.

作者信息

Bonmassar E, Bonmassar A, Vadlamudi S, Goldin A

出版信息

Cancer Res. 1972 Jul;32(7):1446-50.

PMID:4402275

Abstract

摘要

相似文献

Antigenic changes of L1210 leukemia in mice treated with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide.用5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺治疗的小鼠中L1210白血病的抗原变化

Cancer Res. 1972 Jul;32(7):1446-50.

Cell-mediated response to a mouse leukemic subline antigenically altered following drug treatment in vivo.对体内药物治疗后抗原性改变的小鼠白血病亚系抗原的细胞介导反应。

Cancer Chemother Rep. 1974 May-Jun;58(3):325-30.

Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).抗白血病药物对接种了对5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺（NSC-45388）或5-（3,3-双（2-氯乙基）-1-三氮烯基）咪唑-4-甲酰胺（NSC-82196）耐药的白血病L1210变体的小鼠的有效性。

Cancer Chemother Rep. 1971 Feb;55(1):9-28.

Attempt to alter antigenic structure of normal tissues by treatment with dimethyl-triazeno-imidazole-carboxamide in vivo.尝试通过在体内用二甲基三氮烯咪唑甲酰胺处理来改变正常组织的抗原结构。

Experientia. 1976 Jun 15;32(6):741-2. doi: 10.1007/BF01919863.

Role of 4-diazoimidazole-5-carboxamide in the action of the antitumor agent 5(4)-(3,3-dimethyl-1-triazeno) imidazole-4-(5)carboxamide in Bacillus subtilis.4-重氮咪唑-5-甲酰胺在枯草芽孢杆菌中抗肿瘤剂5(4)-(3,3-二甲基-1-三氮烯)咪唑-4-(5)甲酰胺作用中的角色

Biochem Pharmacol. 1972 Aug 1;21(15):2065-76. doi: 10.1016/0006-2952(72)90160-8.

The effects of treatments with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in darkness and in light on survival and progression in Chinese hamster ovary cells in vitro.5-（3,3-二甲基-1-三氮烯基）咪唑-4-甲酰胺在黑暗和光照条件下处理对体外培养的中国仓鼠卵巢细胞存活和进展的影响

Cancer Res. 1974 Aug;34(8):1921-5.

Immunosensitivity and histocompatibility antigens in drug-altered leukemic cells.药物改变的白血病细胞中的免疫敏感性和组织相容性抗原。

Cancer Res. 1976 Jan;36(1):222-7.

Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.在携带L1210白血病免疫原性亚系的BALB-c×DBA-2 Cr F1小鼠中进行过继性免疫治疗。

Cancer Res. 1974 Nov;34(11):3044-8.

[Preliminary studies of the evaluation of immunodepressive activity in L1210 leukemia allografts in mice].[小鼠L1210白血病同种异体移植中免疫抑制活性评估的初步研究]

Boll Soc Ital Biol Sper. 1970 Mar 15;46(5):230-3.

In vitro generation of a highly immunogenic subline of L1210 leukemia following exposure to 5-(3,3'-dimethyl-1-triazeno)imidazole-4-carboxamide.暴露于5-（3,3'-二甲基-1-三氮烯基）咪唑-4-甲酰胺后体外产生L1210白血病的高免疫原性子系。

Cancer Res. 1981 Jun;41(6):2476-82.

引用本文的文献

Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?远隔效应与药物诱导的异种移植物形成：癌症治疗的战略联盟？

Int J Mol Sci. 2021 Oct 1;22(19):10672. doi: 10.3390/ijms221910672.

Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.肿瘤免疫疗法：药物诱导的新抗原（异种化）与免疫检查点抑制剂。

Oncotarget. 2017 Jun 20;8(25):41641-41669. doi: 10.18632/oncotarget.16335.

Effects of prolonged treatment with decarbazine on tumor metastatic potential in mice bearing Lewis lung carcinoma.达卡巴嗪长期治疗对携带Lewis肺癌小鼠肿瘤转移潜能的影响。

Clin Exp Metastasis. 1995 Mar;13(2):97-104. doi: 10.1007/BF00133614.

Tumor progression in metastasis: an experimental approach using lectin resistant tumor variants.转移中的肿瘤进展：一种使用凝集素抗性肿瘤变体的实验方法。

Cancer Metastasis Rev. 1982;1(2):99-140. doi: 10.1007/BF00048223.

Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies.用三氮烯衍生物对小鼠淋巴瘤细胞进行化学异种化：免疫毒理学研究。

Cancer Immunol Immunother. 1984;17(3):213-7. doi: 10.1007/BF00205488.

Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives.芳基三氮烯衍生物体外处理后小鼠淋巴瘤细胞的免疫原性变化

Cancer Immunol Immunother. 1984;16(3):157-61. doi: 10.1007/BF00205422.

Adoptive immunity in mice challenged with L1210/DTIC clones.用L1210/DTIC克隆攻击的小鼠中的过继免疫。

Cancer Immunol Immunother. 1987;24(1):64-7. doi: 10.1007/BF00199834.

Chemical xenogenization of experimental tumors.实验性肿瘤的化学异种移植

Cancer Metastasis Rev. 1987;6(2):93-111. doi: 10.1007/BF00052845.

Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens.对化学异种移植肿瘤的细胞介导免疫。I. 特异性抗血清的抑制作用及新抗原与H-2的关联

Cancer Immunol Immunother. 1988;26(1):48-54. doi: 10.1007/BF00199847.

Two antiemetic regimens do not impair chemical xenogenization induced in vivo by 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide.两种止吐方案不会损害5-（3,3-二甲基-1-三氮烯基）-咪唑-4-甲酰胺在体内诱导的化学异种移植。

Cancer Chemother Pharmacol. 1989;24(6):359-62. doi: 10.1007/BF00257442.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验